is hims semaglutide fda approved & Hers stock falls 25% as curtails compounded GLP-1s is semaglutide compound fda approved

While exercise is beneficial for diabetes management and weight loss, patients should avoid sudden intense exertion during the first weeks of therapy or after dose increases

(2025, September 30)

Weight loss effects vary by population, with approximately 5-11% in diabetes trials and 15-21% in obesity trials (SURMOUNT program) at the highest doses

If your dose consistently makes you feel like you need a long nap, scheduling your injection for a Friday or Saturday evening might be the best move

Jul 2024;127:63-74

Chronic GLP-1 Receptor Activation by Exendin-4 Induces Expansion of Pancreatic Duct Glands in Rats and Accelerates Formation of Dysplastic Lesions and Chronic Pancreatitis in the Kras(G12D) Mouse Model